02.06.2000, Tallinna Farmaatsiatehas, TLN

TALLINNA FARMAATSIATEHAS

ANNOUNCEMENT



COMMENTARY TO BNS NEWS PUBLISHED IN ÄRIPÄEV NEWSPAPER



The boards of Tallinna Farmaatsiatehase AS and RAS Grindeks are in 

the process of designing TFT strategic development principles, in a 

bid to bring the medicine production in line with the good 

manufacturing practice (GMP). The need for investments and potential 

sources of financing are under discussion. Currently the boards have 

not made any decisions on the aforementioned topic.





Raivo Unt

CFO

+372 61 20 201